GASTROINTEST ENDOSC 润色咨询

GASTROINTESTINAL ENDOSCOPY

出版年份:1965 年文章数:3497 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:14.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2243644, encodeId=6c62224364418, content=case,<br>9.26投稿第一次,<br>10.25小修第二次最后提交,通讯作者收到等编辑评论的通知,<br>排队等评论等了40天,<br>12.6杂志社accept。<br><br>两次小修我都很及时,都是第二天反馈提交。<br><br>一共2个月零10天,整篇文章尘埃落定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:18:56 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2253552, encodeId=ec332253552cb, content=审稿速度:12.0<br>偏重的研究方向:消化内镜;临床<br>经验分享:GIE杂志相对友好,如果文章质量还可以,会考虑送审;如果文章质量不行,会直接拒绝,或者建议转投iGIE。曾经投过两篇,其中一篇送审后被拒;另一篇大修后接收。GIE投稿状态汇总:<br>Submitted to Journal 提交至杂志<br>With Editor 编辑处理中<br>Alt Reviewer Invited 邀请审稿人<br>Review(s) Pending 审稿待批<br>Required Reviews Completed 审稿完成<br>Decision in Process 编辑决定中<br>Reject/Major Revision/Minor Revision/Accept 拒绝/大修/小修/接收<br>接收后1-2天签订版权**协议<br>接收后3-4天Online<br>接收后1个月Proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96395584440, createdName=686639, createdTime=Tue Feb 25 15:45:22 CST 2025, time=2025-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2247070, encodeId=c962224e0705b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:准备投,投稿手续麻烦吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92d79260570, createdName=ms1000000100138153, createdTime=Wed Jan 08 10:34:43 CST 2025, time=2025-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162739, encodeId=db892162e39dd, content=在GIE发了10篇letter了,以前因为单位还算点小分,现在已经完全不算了,不过因为阅读习惯,每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些,主要因为发表的article数量和review数量都明显更多,内容也更庞杂,所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了,没有的话就是没送审。文章如果送审了的话初审很快,一般一个月以内肯定有初步决定,但是到最后接收一般要三四个月。内容方面强调创新,前瞻性的新技术哪怕样本量比较小,实验设计比较简单也存在发的可能,相反回顾性的单中心一般很困难,国内基本也就复旦中山等几个医院有可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Sat Oct 14 10:48:11 CST 2023, time=2023-10-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169392, encodeId=23b52169392e0, content=返修后被拒,白白浪费3个多月,哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a228360697, createdName=ms6000001032864519, createdTime=Sat Nov 18 22:25:57 CST 2023, time=2023-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2243653, encodeId=3871224365354, content=审稿速度:1.0<br>偏重的研究方向:内镜<br>经验分享:GIE这篇文章, 9.26投稿第一次, 10.25小修第二次最后提交,通讯作者收到等评论的通知,等评论等了40天, 到12.6杂志社accept。 两次小修我都很及时,都是第二天反馈提交。 为啥评论的不显示呢 一共2个月零10天,整篇文章尘埃落定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:47:47 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2239174, encodeId=30b922391e400, content=偏重的研究方向:内镜<br>经验分享:有投过病例的小伙伴吗,大概流程是咋样的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cbf9048485, createdName=ms6000000833014348, createdTime=Mon Nov 25 23:14:49 CST 2024, time=2024-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069608, encodeId=6f1f106960805, content=偏重的研究方向:内镜;临床<br>经验分享:美国消化内镜学会会刊,相比endoscopy,article和review(meta分析)的发表量要更多,中国人文章出现的频率也要高很多。总体来说关注这么多年,也投了N次(虽然没中几次),感觉对创新性的要求比较高,其次是方法,再次是样本量。一审很快,article和review基本送审一个多月都会审回来,但是整个流程很消耗时间,因为编辑一般都会决定很久,decision in process持续N天,最后还是拒搞。case,letter一般是两周左右给结果,但是发表时间很漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Fri Nov 12 12:59:48 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神,alt reviewer invited是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208345, encodeId=2feb220834520, content=偏重的研究方向:RCT<br>经验分享:投稿20天,还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Tue Jun 04 21:44:35 CST 2024, time=2024-06-04, status=1, ipAttribution=雪兰莪)]
    2024-12-20 94752114 来自山东省

    case,
    9.26投稿第一次,
    10.25小修第二次最后提交,通讯作者收到等编辑评论的通知,
    排队等评论等了40天,
    12.6杂志社accept。

    两次小修我都很及时,都是第二天反馈提交。

    一共2个月零10天,整篇文章尘埃落定。

    5

    展开5条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2243644, encodeId=6c62224364418, content=case,<br>9.26投稿第一次,<br>10.25小修第二次最后提交,通讯作者收到等编辑评论的通知,<br>排队等评论等了40天,<br>12.6杂志社accept。<br><br>两次小修我都很及时,都是第二天反馈提交。<br><br>一共2个月零10天,整篇文章尘埃落定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:18:56 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2253552, encodeId=ec332253552cb, content=审稿速度:12.0<br>偏重的研究方向:消化内镜;临床<br>经验分享:GIE杂志相对友好,如果文章质量还可以,会考虑送审;如果文章质量不行,会直接拒绝,或者建议转投iGIE。曾经投过两篇,其中一篇送审后被拒;另一篇大修后接收。GIE投稿状态汇总:<br>Submitted to Journal 提交至杂志<br>With Editor 编辑处理中<br>Alt Reviewer Invited 邀请审稿人<br>Review(s) Pending 审稿待批<br>Required Reviews Completed 审稿完成<br>Decision in Process 编辑决定中<br>Reject/Major Revision/Minor Revision/Accept 拒绝/大修/小修/接收<br>接收后1-2天签订版权**协议<br>接收后3-4天Online<br>接收后1个月Proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96395584440, createdName=686639, createdTime=Tue Feb 25 15:45:22 CST 2025, time=2025-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2247070, encodeId=c962224e0705b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:准备投,投稿手续麻烦吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92d79260570, createdName=ms1000000100138153, createdTime=Wed Jan 08 10:34:43 CST 2025, time=2025-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162739, encodeId=db892162e39dd, content=在GIE发了10篇letter了,以前因为单位还算点小分,现在已经完全不算了,不过因为阅读习惯,每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些,主要因为发表的article数量和review数量都明显更多,内容也更庞杂,所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了,没有的话就是没送审。文章如果送审了的话初审很快,一般一个月以内肯定有初步决定,但是到最后接收一般要三四个月。内容方面强调创新,前瞻性的新技术哪怕样本量比较小,实验设计比较简单也存在发的可能,相反回顾性的单中心一般很困难,国内基本也就复旦中山等几个医院有可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Sat Oct 14 10:48:11 CST 2023, time=2023-10-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169392, encodeId=23b52169392e0, content=返修后被拒,白白浪费3个多月,哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a228360697, createdName=ms6000001032864519, createdTime=Sat Nov 18 22:25:57 CST 2023, time=2023-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2243653, encodeId=3871224365354, content=审稿速度:1.0<br>偏重的研究方向:内镜<br>经验分享:GIE这篇文章, 9.26投稿第一次, 10.25小修第二次最后提交,通讯作者收到等评论的通知,等评论等了40天, 到12.6杂志社accept。 两次小修我都很及时,都是第二天反馈提交。 为啥评论的不显示呢 一共2个月零10天,整篇文章尘埃落定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:47:47 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2239174, encodeId=30b922391e400, content=偏重的研究方向:内镜<br>经验分享:有投过病例的小伙伴吗,大概流程是咋样的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cbf9048485, createdName=ms6000000833014348, createdTime=Mon Nov 25 23:14:49 CST 2024, time=2024-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069608, encodeId=6f1f106960805, content=偏重的研究方向:内镜;临床<br>经验分享:美国消化内镜学会会刊,相比endoscopy,article和review(meta分析)的发表量要更多,中国人文章出现的频率也要高很多。总体来说关注这么多年,也投了N次(虽然没中几次),感觉对创新性的要求比较高,其次是方法,再次是样本量。一审很快,article和review基本送审一个多月都会审回来,但是整个流程很消耗时间,因为编辑一般都会决定很久,decision in process持续N天,最后还是拒搞。case,letter一般是两周左右给结果,但是发表时间很漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Fri Nov 12 12:59:48 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神,alt reviewer invited是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208345, encodeId=2feb220834520, content=偏重的研究方向:RCT<br>经验分享:投稿20天,还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Tue Jun 04 21:44:35 CST 2024, time=2024-06-04, status=1, ipAttribution=雪兰莪)]
    2025-02-25 686639 来自山东省

    审稿速度:12.0
    偏重的研究方向:消化内镜;临床
    经验分享:GIE杂志相对友好,如果文章质量还可以,会考虑送审;如果文章质量不行,会直接拒绝,或者建议转投iGIE。曾经投过两篇,其中一篇送审后被拒;另一篇大修后接收。GIE投稿状态汇总:
    Submitted to Journal 提交至杂志
    With Editor 编辑处理中
    Alt Reviewer Invited 邀请审稿人
    Review(s) Pending 审稿待批
    Required Reviews Completed 审稿完成
    Decision in Process 编辑决定中
    Reject/Major Revision/Minor Revision/Accept 拒绝/大修/小修/接收
    接收后1-2天签订版权**协议
    接收后3-4天Online
    接收后1个月Proof

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2243644, encodeId=6c62224364418, content=case,<br>9.26投稿第一次,<br>10.25小修第二次最后提交,通讯作者收到等编辑评论的通知,<br>排队等评论等了40天,<br>12.6杂志社accept。<br><br>两次小修我都很及时,都是第二天反馈提交。<br><br>一共2个月零10天,整篇文章尘埃落定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:18:56 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2253552, encodeId=ec332253552cb, content=审稿速度:12.0<br>偏重的研究方向:消化内镜;临床<br>经验分享:GIE杂志相对友好,如果文章质量还可以,会考虑送审;如果文章质量不行,会直接拒绝,或者建议转投iGIE。曾经投过两篇,其中一篇送审后被拒;另一篇大修后接收。GIE投稿状态汇总:<br>Submitted to Journal 提交至杂志<br>With Editor 编辑处理中<br>Alt Reviewer Invited 邀请审稿人<br>Review(s) Pending 审稿待批<br>Required Reviews Completed 审稿完成<br>Decision in Process 编辑决定中<br>Reject/Major Revision/Minor Revision/Accept 拒绝/大修/小修/接收<br>接收后1-2天签订版权**协议<br>接收后3-4天Online<br>接收后1个月Proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96395584440, createdName=686639, createdTime=Tue Feb 25 15:45:22 CST 2025, time=2025-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2247070, encodeId=c962224e0705b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:准备投,投稿手续麻烦吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92d79260570, createdName=ms1000000100138153, createdTime=Wed Jan 08 10:34:43 CST 2025, time=2025-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162739, encodeId=db892162e39dd, content=在GIE发了10篇letter了,以前因为单位还算点小分,现在已经完全不算了,不过因为阅读习惯,每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些,主要因为发表的article数量和review数量都明显更多,内容也更庞杂,所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了,没有的话就是没送审。文章如果送审了的话初审很快,一般一个月以内肯定有初步决定,但是到最后接收一般要三四个月。内容方面强调创新,前瞻性的新技术哪怕样本量比较小,实验设计比较简单也存在发的可能,相反回顾性的单中心一般很困难,国内基本也就复旦中山等几个医院有可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Sat Oct 14 10:48:11 CST 2023, time=2023-10-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169392, encodeId=23b52169392e0, content=返修后被拒,白白浪费3个多月,哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a228360697, createdName=ms6000001032864519, createdTime=Sat Nov 18 22:25:57 CST 2023, time=2023-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2243653, encodeId=3871224365354, content=审稿速度:1.0<br>偏重的研究方向:内镜<br>经验分享:GIE这篇文章, 9.26投稿第一次, 10.25小修第二次最后提交,通讯作者收到等评论的通知,等评论等了40天, 到12.6杂志社accept。 两次小修我都很及时,都是第二天反馈提交。 为啥评论的不显示呢 一共2个月零10天,整篇文章尘埃落定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:47:47 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2239174, encodeId=30b922391e400, content=偏重的研究方向:内镜<br>经验分享:有投过病例的小伙伴吗,大概流程是咋样的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cbf9048485, createdName=ms6000000833014348, createdTime=Mon Nov 25 23:14:49 CST 2024, time=2024-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069608, encodeId=6f1f106960805, content=偏重的研究方向:内镜;临床<br>经验分享:美国消化内镜学会会刊,相比endoscopy,article和review(meta分析)的发表量要更多,中国人文章出现的频率也要高很多。总体来说关注这么多年,也投了N次(虽然没中几次),感觉对创新性的要求比较高,其次是方法,再次是样本量。一审很快,article和review基本送审一个多月都会审回来,但是整个流程很消耗时间,因为编辑一般都会决定很久,decision in process持续N天,最后还是拒搞。case,letter一般是两周左右给结果,但是发表时间很漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Fri Nov 12 12:59:48 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神,alt reviewer invited是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208345, encodeId=2feb220834520, content=偏重的研究方向:RCT<br>经验分享:投稿20天,还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Tue Jun 04 21:44:35 CST 2024, time=2024-06-04, status=1, ipAttribution=雪兰莪)]
    2025-01-08 ms1000000100138153 来自广东省

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:准备投,投稿手续麻烦吗

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2243644, encodeId=6c62224364418, content=case,<br>9.26投稿第一次,<br>10.25小修第二次最后提交,通讯作者收到等编辑评论的通知,<br>排队等评论等了40天,<br>12.6杂志社accept。<br><br>两次小修我都很及时,都是第二天反馈提交。<br><br>一共2个月零10天,整篇文章尘埃落定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:18:56 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2253552, encodeId=ec332253552cb, content=审稿速度:12.0<br>偏重的研究方向:消化内镜;临床<br>经验分享:GIE杂志相对友好,如果文章质量还可以,会考虑送审;如果文章质量不行,会直接拒绝,或者建议转投iGIE。曾经投过两篇,其中一篇送审后被拒;另一篇大修后接收。GIE投稿状态汇总:<br>Submitted to Journal 提交至杂志<br>With Editor 编辑处理中<br>Alt Reviewer Invited 邀请审稿人<br>Review(s) Pending 审稿待批<br>Required Reviews Completed 审稿完成<br>Decision in Process 编辑决定中<br>Reject/Major Revision/Minor Revision/Accept 拒绝/大修/小修/接收<br>接收后1-2天签订版权**协议<br>接收后3-4天Online<br>接收后1个月Proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96395584440, createdName=686639, createdTime=Tue Feb 25 15:45:22 CST 2025, time=2025-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2247070, encodeId=c962224e0705b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:准备投,投稿手续麻烦吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92d79260570, createdName=ms1000000100138153, createdTime=Wed Jan 08 10:34:43 CST 2025, time=2025-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162739, encodeId=db892162e39dd, content=在GIE发了10篇letter了,以前因为单位还算点小分,现在已经完全不算了,不过因为阅读习惯,每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些,主要因为发表的article数量和review数量都明显更多,内容也更庞杂,所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了,没有的话就是没送审。文章如果送审了的话初审很快,一般一个月以内肯定有初步决定,但是到最后接收一般要三四个月。内容方面强调创新,前瞻性的新技术哪怕样本量比较小,实验设计比较简单也存在发的可能,相反回顾性的单中心一般很困难,国内基本也就复旦中山等几个医院有可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Sat Oct 14 10:48:11 CST 2023, time=2023-10-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169392, encodeId=23b52169392e0, content=返修后被拒,白白浪费3个多月,哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a228360697, createdName=ms6000001032864519, createdTime=Sat Nov 18 22:25:57 CST 2023, time=2023-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2243653, encodeId=3871224365354, content=审稿速度:1.0<br>偏重的研究方向:内镜<br>经验分享:GIE这篇文章, 9.26投稿第一次, 10.25小修第二次最后提交,通讯作者收到等评论的通知,等评论等了40天, 到12.6杂志社accept。 两次小修我都很及时,都是第二天反馈提交。 为啥评论的不显示呢 一共2个月零10天,整篇文章尘埃落定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:47:47 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2239174, encodeId=30b922391e400, content=偏重的研究方向:内镜<br>经验分享:有投过病例的小伙伴吗,大概流程是咋样的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cbf9048485, createdName=ms6000000833014348, createdTime=Mon Nov 25 23:14:49 CST 2024, time=2024-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069608, encodeId=6f1f106960805, content=偏重的研究方向:内镜;临床<br>经验分享:美国消化内镜学会会刊,相比endoscopy,article和review(meta分析)的发表量要更多,中国人文章出现的频率也要高很多。总体来说关注这么多年,也投了N次(虽然没中几次),感觉对创新性的要求比较高,其次是方法,再次是样本量。一审很快,article和review基本送审一个多月都会审回来,但是整个流程很消耗时间,因为编辑一般都会决定很久,decision in process持续N天,最后还是拒搞。case,letter一般是两周左右给结果,但是发表时间很漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Fri Nov 12 12:59:48 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神,alt reviewer invited是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208345, encodeId=2feb220834520, content=偏重的研究方向:RCT<br>经验分享:投稿20天,还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Tue Jun 04 21:44:35 CST 2024, time=2024-06-04, status=1, ipAttribution=雪兰莪)]
    2023-10-14 doctor10 来自四川省

    在GIE发了10篇letter了,以前因为单位还算点小分,现在已经完全不算了,不过因为阅读习惯,每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些,主要因为发表的article数量和review数量都明显更多,内容也更庞杂,所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了,没有的话就是没送审。文章如果送审了的话初审很快,一般一个月以内肯定有初步决定,但是到最后接收一般要三四个月。内容方面强调创新,前瞻性的新技术哪怕样本量比较小,实验设计比较简单也存在发的可能,相反回顾性的单中心一般很困难,国内基本也就复旦中山等几个医院有可能

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2243644, encodeId=6c62224364418, content=case,<br>9.26投稿第一次,<br>10.25小修第二次最后提交,通讯作者收到等编辑评论的通知,<br>排队等评论等了40天,<br>12.6杂志社accept。<br><br>两次小修我都很及时,都是第二天反馈提交。<br><br>一共2个月零10天,整篇文章尘埃落定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:18:56 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2253552, encodeId=ec332253552cb, content=审稿速度:12.0<br>偏重的研究方向:消化内镜;临床<br>经验分享:GIE杂志相对友好,如果文章质量还可以,会考虑送审;如果文章质量不行,会直接拒绝,或者建议转投iGIE。曾经投过两篇,其中一篇送审后被拒;另一篇大修后接收。GIE投稿状态汇总:<br>Submitted to Journal 提交至杂志<br>With Editor 编辑处理中<br>Alt Reviewer Invited 邀请审稿人<br>Review(s) Pending 审稿待批<br>Required Reviews Completed 审稿完成<br>Decision in Process 编辑决定中<br>Reject/Major Revision/Minor Revision/Accept 拒绝/大修/小修/接收<br>接收后1-2天签订版权**协议<br>接收后3-4天Online<br>接收后1个月Proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96395584440, createdName=686639, createdTime=Tue Feb 25 15:45:22 CST 2025, time=2025-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2247070, encodeId=c962224e0705b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:准备投,投稿手续麻烦吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92d79260570, createdName=ms1000000100138153, createdTime=Wed Jan 08 10:34:43 CST 2025, time=2025-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162739, encodeId=db892162e39dd, content=在GIE发了10篇letter了,以前因为单位还算点小分,现在已经完全不算了,不过因为阅读习惯,每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些,主要因为发表的article数量和review数量都明显更多,内容也更庞杂,所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了,没有的话就是没送审。文章如果送审了的话初审很快,一般一个月以内肯定有初步决定,但是到最后接收一般要三四个月。内容方面强调创新,前瞻性的新技术哪怕样本量比较小,实验设计比较简单也存在发的可能,相反回顾性的单中心一般很困难,国内基本也就复旦中山等几个医院有可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Sat Oct 14 10:48:11 CST 2023, time=2023-10-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169392, encodeId=23b52169392e0, content=返修后被拒,白白浪费3个多月,哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a228360697, createdName=ms6000001032864519, createdTime=Sat Nov 18 22:25:57 CST 2023, time=2023-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2243653, encodeId=3871224365354, content=审稿速度:1.0<br>偏重的研究方向:内镜<br>经验分享:GIE这篇文章, 9.26投稿第一次, 10.25小修第二次最后提交,通讯作者收到等评论的通知,等评论等了40天, 到12.6杂志社accept。 两次小修我都很及时,都是第二天反馈提交。 为啥评论的不显示呢 一共2个月零10天,整篇文章尘埃落定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:47:47 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2239174, encodeId=30b922391e400, content=偏重的研究方向:内镜<br>经验分享:有投过病例的小伙伴吗,大概流程是咋样的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cbf9048485, createdName=ms6000000833014348, createdTime=Mon Nov 25 23:14:49 CST 2024, time=2024-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069608, encodeId=6f1f106960805, content=偏重的研究方向:内镜;临床<br>经验分享:美国消化内镜学会会刊,相比endoscopy,article和review(meta分析)的发表量要更多,中国人文章出现的频率也要高很多。总体来说关注这么多年,也投了N次(虽然没中几次),感觉对创新性的要求比较高,其次是方法,再次是样本量。一审很快,article和review基本送审一个多月都会审回来,但是整个流程很消耗时间,因为编辑一般都会决定很久,decision in process持续N天,最后还是拒搞。case,letter一般是两周左右给结果,但是发表时间很漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Fri Nov 12 12:59:48 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神,alt reviewer invited是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208345, encodeId=2feb220834520, content=偏重的研究方向:RCT<br>经验分享:投稿20天,还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Tue Jun 04 21:44:35 CST 2024, time=2024-06-04, status=1, ipAttribution=雪兰莪)]
    2023-11-18 ms6000001032864519 来自山东省

    返修后被拒,白白浪费3个多月,哎

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2243644, encodeId=6c62224364418, content=case,<br>9.26投稿第一次,<br>10.25小修第二次最后提交,通讯作者收到等编辑评论的通知,<br>排队等评论等了40天,<br>12.6杂志社accept。<br><br>两次小修我都很及时,都是第二天反馈提交。<br><br>一共2个月零10天,整篇文章尘埃落定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:18:56 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2253552, encodeId=ec332253552cb, content=审稿速度:12.0<br>偏重的研究方向:消化内镜;临床<br>经验分享:GIE杂志相对友好,如果文章质量还可以,会考虑送审;如果文章质量不行,会直接拒绝,或者建议转投iGIE。曾经投过两篇,其中一篇送审后被拒;另一篇大修后接收。GIE投稿状态汇总:<br>Submitted to Journal 提交至杂志<br>With Editor 编辑处理中<br>Alt Reviewer Invited 邀请审稿人<br>Review(s) Pending 审稿待批<br>Required Reviews Completed 审稿完成<br>Decision in Process 编辑决定中<br>Reject/Major Revision/Minor Revision/Accept 拒绝/大修/小修/接收<br>接收后1-2天签订版权**协议<br>接收后3-4天Online<br>接收后1个月Proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96395584440, createdName=686639, createdTime=Tue Feb 25 15:45:22 CST 2025, time=2025-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2247070, encodeId=c962224e0705b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:准备投,投稿手续麻烦吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92d79260570, createdName=ms1000000100138153, createdTime=Wed Jan 08 10:34:43 CST 2025, time=2025-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162739, encodeId=db892162e39dd, content=在GIE发了10篇letter了,以前因为单位还算点小分,现在已经完全不算了,不过因为阅读习惯,每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些,主要因为发表的article数量和review数量都明显更多,内容也更庞杂,所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了,没有的话就是没送审。文章如果送审了的话初审很快,一般一个月以内肯定有初步决定,但是到最后接收一般要三四个月。内容方面强调创新,前瞻性的新技术哪怕样本量比较小,实验设计比较简单也存在发的可能,相反回顾性的单中心一般很困难,国内基本也就复旦中山等几个医院有可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Sat Oct 14 10:48:11 CST 2023, time=2023-10-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169392, encodeId=23b52169392e0, content=返修后被拒,白白浪费3个多月,哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a228360697, createdName=ms6000001032864519, createdTime=Sat Nov 18 22:25:57 CST 2023, time=2023-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2243653, encodeId=3871224365354, content=审稿速度:1.0<br>偏重的研究方向:内镜<br>经验分享:GIE这篇文章, 9.26投稿第一次, 10.25小修第二次最后提交,通讯作者收到等评论的通知,等评论等了40天, 到12.6杂志社accept。 两次小修我都很及时,都是第二天反馈提交。 为啥评论的不显示呢 一共2个月零10天,整篇文章尘埃落定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:47:47 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2239174, encodeId=30b922391e400, content=偏重的研究方向:内镜<br>经验分享:有投过病例的小伙伴吗,大概流程是咋样的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cbf9048485, createdName=ms6000000833014348, createdTime=Mon Nov 25 23:14:49 CST 2024, time=2024-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069608, encodeId=6f1f106960805, content=偏重的研究方向:内镜;临床<br>经验分享:美国消化内镜学会会刊,相比endoscopy,article和review(meta分析)的发表量要更多,中国人文章出现的频率也要高很多。总体来说关注这么多年,也投了N次(虽然没中几次),感觉对创新性的要求比较高,其次是方法,再次是样本量。一审很快,article和review基本送审一个多月都会审回来,但是整个流程很消耗时间,因为编辑一般都会决定很久,decision in process持续N天,最后还是拒搞。case,letter一般是两周左右给结果,但是发表时间很漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Fri Nov 12 12:59:48 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神,alt reviewer invited是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208345, encodeId=2feb220834520, content=偏重的研究方向:RCT<br>经验分享:投稿20天,还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Tue Jun 04 21:44:35 CST 2024, time=2024-06-04, status=1, ipAttribution=雪兰莪)]
    2024-12-20 94752114 来自山东省

    审稿速度:1.0
    偏重的研究方向:内镜
    经验分享:GIE这篇文章, 9.26投稿第一次, 10.25小修第二次最后提交,通讯作者收到等评论的通知,等评论等了40天, 到12.6杂志社accept。 两次小修我都很及时,都是第二天反馈提交。 为啥评论的不显示呢 一共2个月零10天,整篇文章尘埃落定。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2243644, encodeId=6c62224364418, content=case,<br>9.26投稿第一次,<br>10.25小修第二次最后提交,通讯作者收到等编辑评论的通知,<br>排队等评论等了40天,<br>12.6杂志社accept。<br><br>两次小修我都很及时,都是第二天反馈提交。<br><br>一共2个月零10天,整篇文章尘埃落定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:18:56 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2253552, encodeId=ec332253552cb, content=审稿速度:12.0<br>偏重的研究方向:消化内镜;临床<br>经验分享:GIE杂志相对友好,如果文章质量还可以,会考虑送审;如果文章质量不行,会直接拒绝,或者建议转投iGIE。曾经投过两篇,其中一篇送审后被拒;另一篇大修后接收。GIE投稿状态汇总:<br>Submitted to Journal 提交至杂志<br>With Editor 编辑处理中<br>Alt Reviewer Invited 邀请审稿人<br>Review(s) Pending 审稿待批<br>Required Reviews Completed 审稿完成<br>Decision in Process 编辑决定中<br>Reject/Major Revision/Minor Revision/Accept 拒绝/大修/小修/接收<br>接收后1-2天签订版权**协议<br>接收后3-4天Online<br>接收后1个月Proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96395584440, createdName=686639, createdTime=Tue Feb 25 15:45:22 CST 2025, time=2025-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2247070, encodeId=c962224e0705b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:准备投,投稿手续麻烦吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92d79260570, createdName=ms1000000100138153, createdTime=Wed Jan 08 10:34:43 CST 2025, time=2025-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162739, encodeId=db892162e39dd, content=在GIE发了10篇letter了,以前因为单位还算点小分,现在已经完全不算了,不过因为阅读习惯,每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些,主要因为发表的article数量和review数量都明显更多,内容也更庞杂,所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了,没有的话就是没送审。文章如果送审了的话初审很快,一般一个月以内肯定有初步决定,但是到最后接收一般要三四个月。内容方面强调创新,前瞻性的新技术哪怕样本量比较小,实验设计比较简单也存在发的可能,相反回顾性的单中心一般很困难,国内基本也就复旦中山等几个医院有可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Sat Oct 14 10:48:11 CST 2023, time=2023-10-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169392, encodeId=23b52169392e0, content=返修后被拒,白白浪费3个多月,哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a228360697, createdName=ms6000001032864519, createdTime=Sat Nov 18 22:25:57 CST 2023, time=2023-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2243653, encodeId=3871224365354, content=审稿速度:1.0<br>偏重的研究方向:内镜<br>经验分享:GIE这篇文章, 9.26投稿第一次, 10.25小修第二次最后提交,通讯作者收到等评论的通知,等评论等了40天, 到12.6杂志社accept。 两次小修我都很及时,都是第二天反馈提交。 为啥评论的不显示呢 一共2个月零10天,整篇文章尘埃落定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:47:47 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2239174, encodeId=30b922391e400, content=偏重的研究方向:内镜<br>经验分享:有投过病例的小伙伴吗,大概流程是咋样的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cbf9048485, createdName=ms6000000833014348, createdTime=Mon Nov 25 23:14:49 CST 2024, time=2024-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069608, encodeId=6f1f106960805, content=偏重的研究方向:内镜;临床<br>经验分享:美国消化内镜学会会刊,相比endoscopy,article和review(meta分析)的发表量要更多,中国人文章出现的频率也要高很多。总体来说关注这么多年,也投了N次(虽然没中几次),感觉对创新性的要求比较高,其次是方法,再次是样本量。一审很快,article和review基本送审一个多月都会审回来,但是整个流程很消耗时间,因为编辑一般都会决定很久,decision in process持续N天,最后还是拒搞。case,letter一般是两周左右给结果,但是发表时间很漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Fri Nov 12 12:59:48 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神,alt reviewer invited是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208345, encodeId=2feb220834520, content=偏重的研究方向:RCT<br>经验分享:投稿20天,还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Tue Jun 04 21:44:35 CST 2024, time=2024-06-04, status=1, ipAttribution=雪兰莪)]
    2024-11-25 ms6000000833014348

    偏重的研究方向:内镜
    经验分享:有投过病例的小伙伴吗,大概流程是咋样的

    3

    展开3条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2243644, encodeId=6c62224364418, content=case,<br>9.26投稿第一次,<br>10.25小修第二次最后提交,通讯作者收到等编辑评论的通知,<br>排队等评论等了40天,<br>12.6杂志社accept。<br><br>两次小修我都很及时,都是第二天反馈提交。<br><br>一共2个月零10天,整篇文章尘埃落定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:18:56 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2253552, encodeId=ec332253552cb, content=审稿速度:12.0<br>偏重的研究方向:消化内镜;临床<br>经验分享:GIE杂志相对友好,如果文章质量还可以,会考虑送审;如果文章质量不行,会直接拒绝,或者建议转投iGIE。曾经投过两篇,其中一篇送审后被拒;另一篇大修后接收。GIE投稿状态汇总:<br>Submitted to Journal 提交至杂志<br>With Editor 编辑处理中<br>Alt Reviewer Invited 邀请审稿人<br>Review(s) Pending 审稿待批<br>Required Reviews Completed 审稿完成<br>Decision in Process 编辑决定中<br>Reject/Major Revision/Minor Revision/Accept 拒绝/大修/小修/接收<br>接收后1-2天签订版权**协议<br>接收后3-4天Online<br>接收后1个月Proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96395584440, createdName=686639, createdTime=Tue Feb 25 15:45:22 CST 2025, time=2025-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2247070, encodeId=c962224e0705b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:准备投,投稿手续麻烦吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92d79260570, createdName=ms1000000100138153, createdTime=Wed Jan 08 10:34:43 CST 2025, time=2025-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162739, encodeId=db892162e39dd, content=在GIE发了10篇letter了,以前因为单位还算点小分,现在已经完全不算了,不过因为阅读习惯,每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些,主要因为发表的article数量和review数量都明显更多,内容也更庞杂,所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了,没有的话就是没送审。文章如果送审了的话初审很快,一般一个月以内肯定有初步决定,但是到最后接收一般要三四个月。内容方面强调创新,前瞻性的新技术哪怕样本量比较小,实验设计比较简单也存在发的可能,相反回顾性的单中心一般很困难,国内基本也就复旦中山等几个医院有可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Sat Oct 14 10:48:11 CST 2023, time=2023-10-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169392, encodeId=23b52169392e0, content=返修后被拒,白白浪费3个多月,哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a228360697, createdName=ms6000001032864519, createdTime=Sat Nov 18 22:25:57 CST 2023, time=2023-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2243653, encodeId=3871224365354, content=审稿速度:1.0<br>偏重的研究方向:内镜<br>经验分享:GIE这篇文章, 9.26投稿第一次, 10.25小修第二次最后提交,通讯作者收到等评论的通知,等评论等了40天, 到12.6杂志社accept。 两次小修我都很及时,都是第二天反馈提交。 为啥评论的不显示呢 一共2个月零10天,整篇文章尘埃落定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:47:47 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2239174, encodeId=30b922391e400, content=偏重的研究方向:内镜<br>经验分享:有投过病例的小伙伴吗,大概流程是咋样的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cbf9048485, createdName=ms6000000833014348, createdTime=Mon Nov 25 23:14:49 CST 2024, time=2024-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069608, encodeId=6f1f106960805, content=偏重的研究方向:内镜;临床<br>经验分享:美国消化内镜学会会刊,相比endoscopy,article和review(meta分析)的发表量要更多,中国人文章出现的频率也要高很多。总体来说关注这么多年,也投了N次(虽然没中几次),感觉对创新性的要求比较高,其次是方法,再次是样本量。一审很快,article和review基本送审一个多月都会审回来,但是整个流程很消耗时间,因为编辑一般都会决定很久,decision in process持续N天,最后还是拒搞。case,letter一般是两周左右给结果,但是发表时间很漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Fri Nov 12 12:59:48 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神,alt reviewer invited是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208345, encodeId=2feb220834520, content=偏重的研究方向:RCT<br>经验分享:投稿20天,还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Tue Jun 04 21:44:35 CST 2024, time=2024-06-04, status=1, ipAttribution=雪兰莪)]
    2021-11-12 doctor10

    偏重的研究方向:内镜;临床
    经验分享:美国消化内镜学会会刊,相比endoscopy,article和review(meta分析)的发表量要更多,中国人文章出现的频率也要高很多。总体来说关注这么多年,也投了N次(虽然没中几次),感觉对创新性的要求比较高,其次是方法,再次是样本量。一审很快,article和review基本送审一个多月都会审回来,但是整个流程很消耗时间,因为编辑一般都会决定很久,decision in process持续N天,最后还是拒搞。case,letter一般是两周左右给结果,但是发表时间很漫长

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2243644, encodeId=6c62224364418, content=case,<br>9.26投稿第一次,<br>10.25小修第二次最后提交,通讯作者收到等编辑评论的通知,<br>排队等评论等了40天,<br>12.6杂志社accept。<br><br>两次小修我都很及时,都是第二天反馈提交。<br><br>一共2个月零10天,整篇文章尘埃落定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:18:56 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2253552, encodeId=ec332253552cb, content=审稿速度:12.0<br>偏重的研究方向:消化内镜;临床<br>经验分享:GIE杂志相对友好,如果文章质量还可以,会考虑送审;如果文章质量不行,会直接拒绝,或者建议转投iGIE。曾经投过两篇,其中一篇送审后被拒;另一篇大修后接收。GIE投稿状态汇总:<br>Submitted to Journal 提交至杂志<br>With Editor 编辑处理中<br>Alt Reviewer Invited 邀请审稿人<br>Review(s) Pending 审稿待批<br>Required Reviews Completed 审稿完成<br>Decision in Process 编辑决定中<br>Reject/Major Revision/Minor Revision/Accept 拒绝/大修/小修/接收<br>接收后1-2天签订版权**协议<br>接收后3-4天Online<br>接收后1个月Proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96395584440, createdName=686639, createdTime=Tue Feb 25 15:45:22 CST 2025, time=2025-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2247070, encodeId=c962224e0705b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:准备投,投稿手续麻烦吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92d79260570, createdName=ms1000000100138153, createdTime=Wed Jan 08 10:34:43 CST 2025, time=2025-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162739, encodeId=db892162e39dd, content=在GIE发了10篇letter了,以前因为单位还算点小分,现在已经完全不算了,不过因为阅读习惯,每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些,主要因为发表的article数量和review数量都明显更多,内容也更庞杂,所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了,没有的话就是没送审。文章如果送审了的话初审很快,一般一个月以内肯定有初步决定,但是到最后接收一般要三四个月。内容方面强调创新,前瞻性的新技术哪怕样本量比较小,实验设计比较简单也存在发的可能,相反回顾性的单中心一般很困难,国内基本也就复旦中山等几个医院有可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Sat Oct 14 10:48:11 CST 2023, time=2023-10-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169392, encodeId=23b52169392e0, content=返修后被拒,白白浪费3个多月,哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a228360697, createdName=ms6000001032864519, createdTime=Sat Nov 18 22:25:57 CST 2023, time=2023-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2243653, encodeId=3871224365354, content=审稿速度:1.0<br>偏重的研究方向:内镜<br>经验分享:GIE这篇文章, 9.26投稿第一次, 10.25小修第二次最后提交,通讯作者收到等评论的通知,等评论等了40天, 到12.6杂志社accept。 两次小修我都很及时,都是第二天反馈提交。 为啥评论的不显示呢 一共2个月零10天,整篇文章尘埃落定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:47:47 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2239174, encodeId=30b922391e400, content=偏重的研究方向:内镜<br>经验分享:有投过病例的小伙伴吗,大概流程是咋样的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cbf9048485, createdName=ms6000000833014348, createdTime=Mon Nov 25 23:14:49 CST 2024, time=2024-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069608, encodeId=6f1f106960805, content=偏重的研究方向:内镜;临床<br>经验分享:美国消化内镜学会会刊,相比endoscopy,article和review(meta分析)的发表量要更多,中国人文章出现的频率也要高很多。总体来说关注这么多年,也投了N次(虽然没中几次),感觉对创新性的要求比较高,其次是方法,再次是样本量。一审很快,article和review基本送审一个多月都会审回来,但是整个流程很消耗时间,因为编辑一般都会决定很久,decision in process持续N天,最后还是拒搞。case,letter一般是两周左右给结果,但是发表时间很漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Fri Nov 12 12:59:48 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神,alt reviewer invited是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208345, encodeId=2feb220834520, content=偏重的研究方向:RCT<br>经验分享:投稿20天,还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Tue Jun 04 21:44:35 CST 2024, time=2024-06-04, status=1, ipAttribution=雪兰莪)]
    2022-08-09 sky110319

    请教各位大神,alt reviewer invited是什么意思?

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2243644, encodeId=6c62224364418, content=case,<br>9.26投稿第一次,<br>10.25小修第二次最后提交,通讯作者收到等编辑评论的通知,<br>排队等评论等了40天,<br>12.6杂志社accept。<br><br>两次小修我都很及时,都是第二天反馈提交。<br><br>一共2个月零10天,整篇文章尘埃落定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:18:56 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2253552, encodeId=ec332253552cb, content=审稿速度:12.0<br>偏重的研究方向:消化内镜;临床<br>经验分享:GIE杂志相对友好,如果文章质量还可以,会考虑送审;如果文章质量不行,会直接拒绝,或者建议转投iGIE。曾经投过两篇,其中一篇送审后被拒;另一篇大修后接收。GIE投稿状态汇总:<br>Submitted to Journal 提交至杂志<br>With Editor 编辑处理中<br>Alt Reviewer Invited 邀请审稿人<br>Review(s) Pending 审稿待批<br>Required Reviews Completed 审稿完成<br>Decision in Process 编辑决定中<br>Reject/Major Revision/Minor Revision/Accept 拒绝/大修/小修/接收<br>接收后1-2天签订版权**协议<br>接收后3-4天Online<br>接收后1个月Proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96395584440, createdName=686639, createdTime=Tue Feb 25 15:45:22 CST 2025, time=2025-02-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2247070, encodeId=c962224e0705b, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:准备投,投稿手续麻烦吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92d79260570, createdName=ms1000000100138153, createdTime=Wed Jan 08 10:34:43 CST 2025, time=2025-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162739, encodeId=db892162e39dd, content=在GIE发了10篇letter了,以前因为单位还算点小分,现在已经完全不算了,不过因为阅读习惯,每次遇到感兴趣的文章还是会写letter和作者讨论一下。说一下这个杂志的特点。GIE相比endoscopy还是比较容易中一些,主要因为发表的article数量和review数量都明显更多,内容也更庞杂,所以也更容易出现中国国内的文章。投稿时如果看到review pending就是送审了,没有的话就是没送审。文章如果送审了的话初审很快,一般一个月以内肯定有初步决定,但是到最后接收一般要三四个月。内容方面强调创新,前瞻性的新技术哪怕样本量比较小,实验设计比较简单也存在发的可能,相反回顾性的单中心一般很困难,国内基本也就复旦中山等几个医院有可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Sat Oct 14 10:48:11 CST 2023, time=2023-10-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2169392, encodeId=23b52169392e0, content=返修后被拒,白白浪费3个多月,哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a228360697, createdName=ms6000001032864519, createdTime=Sat Nov 18 22:25:57 CST 2023, time=2023-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2243653, encodeId=3871224365354, content=审稿速度:1.0<br>偏重的研究方向:内镜<br>经验分享:GIE这篇文章, 9.26投稿第一次, 10.25小修第二次最后提交,通讯作者收到等评论的通知,等评论等了40天, 到12.6杂志社accept。 两次小修我都很及时,都是第二天反馈提交。 为啥评论的不显示呢 一共2个月零10天,整篇文章尘埃落定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:47:47 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2239174, encodeId=30b922391e400, content=偏重的研究方向:内镜<br>经验分享:有投过病例的小伙伴吗,大概流程是咋样的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cbf9048485, createdName=ms6000000833014348, createdTime=Mon Nov 25 23:14:49 CST 2024, time=2024-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069608, encodeId=6f1f106960805, content=偏重的研究方向:内镜;临床<br>经验分享:美国消化内镜学会会刊,相比endoscopy,article和review(meta分析)的发表量要更多,中国人文章出现的频率也要高很多。总体来说关注这么多年,也投了N次(虽然没中几次),感觉对创新性的要求比较高,其次是方法,再次是样本量。一审很快,article和review基本送审一个多月都会审回来,但是整个流程很消耗时间,因为编辑一般都会决定很久,decision in process持续N天,最后还是拒搞。case,letter一般是两周左右给结果,但是发表时间很漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5bae5283999, createdName=doctor10, createdTime=Fri Nov 12 12:59:48 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237557, encodeId=2ec2123e55790, content=请教各位大神,alt reviewer invited是什么意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a411631968, createdName=sky110319, createdTime=Tue Aug 09 13:04:57 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2208345, encodeId=2feb220834520, content=偏重的研究方向:RCT<br>经验分享:投稿20天,还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Tue Jun 04 21:44:35 CST 2024, time=2024-06-04, status=1, ipAttribution=雪兰莪)]
    2024-06-04 Latte2024 来自雪兰莪

    偏重的研究方向:RCT
    经验分享:投稿20天,还是with editor

    3

    展开3条回复
共115条页码: 1/12页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分